Transgender youth on gender-affirming hormone therapy have differences in their percent fat and lean mass compared with cisgender youth.
Allowing weight regain as part of maintenance reduces cardiometabolic benefit for many risk factors
There is growing evidence that the addition of triglyceride-lowering medication and lifestyle changes may be valuable in diabetes management.
Increasing evening chronotypes and social jet lag are associated with increased adiposity in adolescent girls.
The effects of cardiometabolic risk factors on cortical thickness are different between men and women, as women with these risk factors are more vulnerable to cortical atrophy than men.
In patients with type 2 diabetes, higher fat mass is associated with a higher risk for major adverse cardiovascular events.
Inclisiran is a chemically synthesized small interfering RNA (siRNA) that targets proprotein convertase subtilisin-kexin type 9 (PCSK9) messenger RNA.
The menopausal transition may be a stronger determinant of serum cardiovascular risk factors than chronologic age.
Even with care in specialty clinics, LDL-C persists above target levels in more than half of patients with familial hypercholesterolemia.
Investigators examined whether pretreatment low-density lipoprotein cholesterol levels and aortic stenosis severity affect lipid-lowering therapy to decrease aortic valve replacement.
Researchers used using observational administrative claims data from the Optum Research Database to retrospectively examine the real-world effect of elevated triglyceride levels on cardiovascular outcomes and medical cost.
Want to read more?
Please login or register first to view this content.
Next post in Metabolic